Vienna, Austria

Peter Steinberger

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 6.9

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2007-2019

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Peter Steinberger: Innovator in Pharmaceutical Composition

Introduction

Peter Steinberger is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of inflammatory conditions. With a total of 3 patents to his name, Steinberger's work has the potential to impact medical treatments significantly.

Latest Patents

One of Steinberger's latest patents focuses on the complement split product C4d for the treatment of inflammatory conditions. This invention relates to a pharmaceutical composition that utilizes C4d to treat various inflammatory issues, including graft rejection, graft versus host disease, autoimmune diseases, and atopy. The patent also discusses the use of C4d multimers and their applications in medicine. Furthermore, it introduces a protein complex comprising C4d interacting with its ILT4 receptor, which may be utilized in screening methods. Additionally, the invention covers antibodies that specifically bind to the C4d multimer or the C4d/ILT4-protein complex.

Career Highlights

Throughout his career, Peter Steinberger has worked with esteemed institutions, including the Medical University of Vienna and Phadia AB. His experience in these organizations has allowed him to develop innovative solutions in the pharmaceutical field.

Collaborations

Steinberger has collaborated with notable colleagues such as Johannes Hofer and Gerhard Zlabinger. These partnerships have contributed to the advancement of his research and inventions.

Conclusion

Peter Steinberger is a distinguished inventor whose work in pharmaceutical compositions has the potential to transform treatments for inflammatory conditions. His innovative patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…